Hypotonia denials in California external review

In the California DMHC record, independent physician reviewers decided 20 published external-review cases involving hypotoniaand overturned the plan’s denial in 90%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
20
2005–2022
Overturned
90%
18 denials reversed

Most-fought treatments for hypotonia

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Physical Therapy9
100%
Occupational Therapy8
87.5%
Speech Therapy3
100%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
15
93.3%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
5
80%
Typical time to a decision
21 days
Most land between 19 and 23 days
Handled as urgent
5%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: The enrollee’s parent has requested authorization and reimbursement for pediatric day health care and private duty nursing/nursing care at home. The record indicates the enrollee is diagnosed with Koolen de Vries Syndrome after genetic testing was done and revealed KANLS1 mutation. The enrollee had been feeding poorly after delivery and magnetic resonance imaging (MRI) of the brain showed dysplastic corpus callosum. She spent approximately four weeks in the Neonatal Intensive Care Unit prior to discharge home, related to her feeding issues. She subsequently underwent gastrostomy tube placement and takes 40% of nutritional needs by mouth, with the rest being delivered via gastrostomy (G) tube. She has hypotonia, eustachian tube dysfunction, tracheomalacia, reflux, silent aspiration, audio neuropathy and developmental delay.
Medical Necessity · 2019 · IMR MN19-31028
Physician 1: The patient is a nine-year-old female who presents with various diagnoses including autism, post-traumatic encephalopathy, static encephalopathy and attention deficit disorder. She has also been diagnosed with verbal dyspraxia. The patient has been receiving occupational therapy including sensory integration therapy with some improvement. The Health Plan has denied authorization for continued occupational therapy on the basis it has not been shown to be efficacious for patients such as this patient.Autism is a complex, difficult disease. There are many treatment modalities, but few are universally accepted. Occupational treatment including a sensory integration component is a reasonable treatment approach for this patient’s diagnoses.
Experimental/Investigational · 2005 · IMR EI05-4330

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for one additional occupational therapy session per week (for a total of two sessions of occupational therapy per week).Findings: The physician reviewer found that records provided for review document that this patient has history of autism spectrum disorder and hypotonia. The patient has been making satisfactory progress in occupational therapy. There is insufficient evidence in the published literature to support that two sessions of occupational therapy per week are more beneficial for young patients with autism spectrum disorder than one occupational therapy session per week.
Medical Necessity · 2022 · IMR MN22-36931
The parent of a 10-year-old female enrollee has requested an array CGH analysis for the treatment of the enrollee’s global developmental delay, hypotonia, macrocephaly, seizure disorder, hypermobility and mildly dysmorphic features. Findings: Three physician reviewers found that this patient has undergone an extensive and thorough evaluation in an attempt to put a name/diagnosis on her collection of symptoms. The proposed array CGH test is not likely to be clinically useful in this setting. There are no significant studies demonstrating it is beneficial in cases such as this, and there is only anecdotal information regarding the possible usefulness of the test.
Experimental/Investigational · 2007 · IMR EI07-6992

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving hypotonia, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for hypotonia? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9